Clinical Trial Update: Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial of LT-02 (phosphatidylcholine) for induction of remission in ulcerative colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LT-02

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED